Credit Suisse’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $780K | Buy |
45,755
+2,853
| +7% | +$48.6K | ﹤0.01% | 2403 |
|
|
2023
Q4 | $437K | Buy |
42,902
+23,423
| +120% | +$239K | ﹤0.01% | 2782 |
|
|
2023
Q3 | $176K | Sell |
19,479
-629
| -3% | -$5.69K | ﹤0.01% | 3041 |
|
|
2023
Q2 | $216K | Buy |
20,108
+9,358
| +87% | +$101K | ﹤0.01% | 3065 |
|
|
2023
Q1 | $110K | Buy |
10,750
+3
| +0% | +$31 | ﹤0.01% | 3183 |
|
|
2022
Q4 | $113K | Buy |
10,747
+184
| +2% | +$1.94K | ﹤0.01% | 3296 |
|
|
2022
Q3 | $135K | Buy |
10,563
+144
| +1% | +$1.84K | ﹤0.01% | 3343 |
|
|
2022
Q2 | $134K | Sell |
10,419
-1,970
| -16% | -$25.3K | ﹤0.01% | 3444 |
|
|
2022
Q1 | $131K | Sell |
12,389
-798
| -6% | -$8.44K | ﹤0.01% | 3439 |
|
|
2021
Q4 | $204K | Buy |
13,187
+3,653
| +38% | +$56.5K | ﹤0.01% | 3433 |
|
|
2021
Q3 | $215K | Buy |
9,534
+503
| +6% | +$11.3K | ﹤0.01% | 3362 |
|
|
2021
Q2 | $233K | Buy |
+9,031
| New | +$233K | ﹤0.01% | 3377 |
|